Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: SouthFloridaGuy who wrote (52648)	3/6/2000 11:18:00 PM
From: Street Hawk	Read Replies (2) \| Respond to of 122087

Biotech craze is getting to you, Puff. I guess you think its a biotech stock, cool cancer idea, and wham-o, you get a billion dollar company? Maybe it will last, I'm not shorting long-term on biotechs quite yet, waiting for the insanity to get even crazier. By the way, can you explain why Janssen Pharmaceutical didn't make a $7 mil. milestone payment leading to losses for the company of $10.1 mil over the last 9 months? Also, the reason NERX went up to 55 was because it announced a cure for cancer found in mice, but NOT humans. Therefore, everything they're doing is speculation at this point. Not even Phase I for this supposed cancer cure. Mice cure does not equal human cure. My money is on IMCL, they're innovative and are capitalized more effectively, NERX is really speculative gamble at this point. Would like to see some Phase III trial progress before putting money down on hype.